4//SEC Filing
Aegerion Pharmaceuticals, Inc. 4
Accession 0001209191-14-053601
CIK 0001338042operating
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 9:36 AM ET
Size
5.1 KB
Accession
0001209191-14-053601
Insider Transaction Report
Form 4
Fitzpatrick Mark J.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2014-08-19$30.64/sh+1,150$35,236→ 9,500 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.57 to $30.68, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338042
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 9:36 AM ET
- Size
- 5.1 KB